Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic.

Katrine BukanToby Pearce-SladeMads EibergMarco TinelliDafna YahavJose TuellsOlivier EpaulardJon G HollerCasper RoedChristian SøborgJens-Ulrik Stæhr JensenZitta Barrella Harboe

Published in: Aging clinical and experimental research (2023)

During the COVID-19 pandemic, we found a decrease in the exclusion of older adults from vaccine trials but no significant change in the inclusion of immunocompromised individulas.

Keyphrases

physical activity
coronavirus disease
sars cov
respiratory failure
intensive care unit
extracorporeal membrane oxygenation
acute respiratory distress syndrome
mechanical ventilation